Suppr超能文献

大环内酯类药物的体外抗立克次氏体活性。

The in-vitro anti-rickettsial activity of macrolides.

作者信息

Keysary A, Itzhaki A, Rubinstein E, Oron C, Keren G

机构信息

Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.

出版信息

J Antimicrob Chemother. 1996 Oct;38(4):727-31. doi: 10.1093/jac/38.4.727.

Abstract

The anti-rickettsial activity of azithromycin and clarithromycin was studied in Vero cells. The rate of rickettsial inhibition-growth caused by both macrolides was determined using rickettsial counts and ELISA. Both macrolides inhibited > 50% the growth of Rickettsia conorii and Rickettsia typhi at concentrations of 1.0 and 0.1 mg/L, respectively. The growth of Coxiella burnetii was inhibited to a rate of > or = 50% at the concentrations of 0.01 and 1.0 mg/L of azithromycin and clarithromycin, respectively.

摘要

在Vero细胞中研究了阿奇霉素和克拉霉素的抗立克次体活性。使用立克次体计数和酶联免疫吸附测定法(ELISA)确定了两种大环内酯类药物引起的立克次体生长抑制率。两种大环内酯类药物分别在浓度为1.0和0.1mg/L时,对康氏立克次体和伤寒立克次体的生长抑制率均>50%。阿奇霉素和克拉霉素分别在浓度为0.01和1.0mg/L时,对贝氏柯克斯体的生长抑制率≥50%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验